The FDA approved TheracosBio’s Brenzavvy as a treatment for type 2 diabetes. But before it won a regulatory nod for controlling blood glucose in adults, it was approved at a different dose (with flavor) as a veterinary product.
TheracosBio Drug Approval Puts It in Competition With Blockbuster Diabetes Meds
